Zobrazeno 1 - 10
of 131
pro vyhledávání: '"Wolfgang, Ramlow"'
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis TherapyREFERENCES.
Platelet abnormalities and secondary thrombocytosis are clinical features of ulcerative colitis (UC) and seem to play a relevant role in pathogenesis. This work analyzed the adsorption characteristics of the adsorber Immunopure.A prospective study wa
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c119799dc6e0d8e72fbf5b34decdda05
https://pubmed.ncbi.nlm.nih.gov/36273320
https://pubmed.ncbi.nlm.nih.gov/36273320
Autor:
Volker J J, Schettler, Christian, Peter, Thomas, Zimmermann, Ulrich, Julius, Eberhard, Roeseler, Georg, Schlieper, Franz, Heigl, Peter, Grützmacher, Iris, Löhlein, Reinhard, Klingel, Bernd, Hohenstein, Wolfgang, Ramlow, Anja, Vogt
Publikováno v:
Therapeutic apheresis and dialysis : official peer-reviewed journal of the International Society for Apheresis, the Japanese Society for Apheresis, the Japanese Society for Dialysis TherapyREFERENCES. 26
During 2012-2020, 89 German apheresis centers collected retrospective and prospective observational data of 2028 patients undergoing regular lipoprotein apheresis (LA) for the German Lipoprotein Apheresis Registry (GLAR). More than 47 500 LA sessions
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::71f8c6556a2971df2651a806385ce64f
https://pubmed.ncbi.nlm.nih.gov/36468337
https://pubmed.ncbi.nlm.nih.gov/36468337
Autor:
Wolfgang Ramlow, Frido Himmelsbach, Franz Heigl, Justyna Kozik-Jaromin, Gerd Schmitz, Ingrid Uhlenbusch-Körwer, Jens Ringel, Frank Leistikow, Eberhard Röseler, Ralf Spitthöver, Rainer Heinzler, Nadim Abdul-Rahman, V.J.J. Schettler
Publikováno v:
Atherosclerosis Supplements. 30:225-231
Background Lipidapheresis was introduced for intractable hyperlipidemia as a more selective therapy than plasma exchange aiming to enhance efficacy and limit side-effects. Although this therapy is regarded safe, multicenter data from routine applicat
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8a982289ac036a8311e8d63d8fd976b5
https://doi.org/10.1016/j.atherosclerosissup.2017.05.036
https://doi.org/10.1016/j.atherosclerosissup.2017.05.036
Autor:
Phuong Hien Nguyen, Wolfgang Ramlow, Axel Dignaß, Julia Morgenstern, Uta Drebber, Andreas Stallmach, Wolfgang Kruis
Publikováno v:
Journal of Crohn'scolitis. 13(7)
Background and Aims In active ulcerative colitis [UC] refractory to mesalazine, escalation to either steroids or immunosuppression is common practice. The efficacy and safety of alternative escalation therapy with a novel leukocyte apheresis device w
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f6c81658d99e1979b41083dcaa6fc599
https://pubmed.ncbi.nlm.nih.gov/30863856
https://pubmed.ncbi.nlm.nih.gov/30863856
Autor:
Elisabeth Steinhagen-Thiessen, Paul D. Thompson, Yunling Du, Anja Vogt, V.J.J. Schettler, Klaus G. Parhofer, Wolfgang Ramlow, Bernd Hohenstein, Josef Leebmann, Marc-Andre Cornier, Stephan P. Babirak, Berndt von Stritzky, Patrick M. Moriarty, Vinaya Simha, Garen Manvelian, P. Barton Duell
Publikováno v:
European Heart Journal. 37:3588-3595
Aim To evaluate the effect of alirocumab on frequency of standard apheresis treatments [weekly or every 2 weeks (Q2W)] in heterozygous familial hypercholesterolaemia (HeFH). Methods and results ODYSSEY ESCAPE ([NCT02326220][1]) was a double-blind stu
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1585d56a6a21d99f6ff2adbc71d4337d
https://doi.org/10.1093/eurheartj/ehw388
https://doi.org/10.1093/eurheartj/ehw388
Autor:
P. Barton Duell, Wolfgang Ramlow, Patrick M. Moriarty, Yunling Du, Emil M. deGoma, Berndt von Stritzky, Vinaya Simha, Paul D. Thompson, Garen Manvelian, Bernd Hohenstein, Elisabeth Steinhagen-Thiessen, Anja Vogt, Klaus G. Parhofer, Stephan P. Babirak
Publikováno v:
Journal of Clinical Lipidology. 10:627-634
Background Many patients with heterozygous familial hypercholesterolemia (HeFH) fail to reach optimal low-density lipoprotein cholesterol (LDL-C) levels with available lipid-lowering medications, including statins, and require treatment using alterna
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dfa135310de117824a512d30e9c65b36
https://doi.org/10.1016/j.jacl.2016.02.003
https://doi.org/10.1016/j.jacl.2016.02.003
Autor:
Polenakovic, Momir H.1 momir@manu.edu.mk
Publikováno v:
Contributions / Prilozi (1857-9345). 2020, Vol. 41 Issue 3, p91-93. 3p.
Autor:
Sreedhar Subramanian, Daniel C. Baumgart, Bruno Bonaz, Gilles Bommelaer, Axel Dignass, Guillaume Cadiot, Richard Makins, Jean-Charles Grimaud, Ayesha Akbar, Christophe Michiels, Christian von Tirpitz, Wolfgang Ramlow, Ailsa Hart, Anton Gillessen, Guillaume Bouguen, Syed Hoque, Stefan Schanz, Jacques Moreau, Purushothaman Premchand
Publikováno v:
Scandinavian Journal of Gastroenterology
Scandinavian Journal of Gastroenterology, 2018, 53 (4), pp.442-448. ⟨10.1080/00365521.2018.1447598⟩
Scandinavian Journal of Gastroenterology, Taylor & Francis, 2018, 53 (4), pp.442-448. ⟨10.1080/00365521.2018.1447598⟩
Scandinavian Journal of Gastroenterology, 2018, 53 (4), pp.442-448. ⟨10.1080/00365521.2018.1447598⟩
Scandinavian Journal of Gastroenterology, Taylor & Francis, 2018, 53 (4), pp.442-448. ⟨10.1080/00365521.2018.1447598⟩
International audience; Objectives Current options for patients with steroid-dependent, chronic-active ulcerative colitis (UC) with insufficient response/intolerance to immunosuppressants (ISs) and/or biologics are limited. The aim of this study was
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a69f8375add893146e79779c4dcc0e11
https://univ-rennes.hal.science/hal-01880990
https://univ-rennes.hal.science/hal-01880990
Autor:
B. Arneth, Franz Heigl, Ben Min-Woo Illigens, Wolfgang Ramlow, Timo Siepmann, D. Siegels, Stefan R. Bornstein, Ulrike Schatz, Reinhard Hettich, Gabriele Siegert, Ulrich Julius, H. Prophet
Publikováno v:
Atherosclerosis Supplements. 18:199-208
Iron deficiency (ID) and iron deficiency anemia (IDA) are common findings in patients undergoing lipoprotein apheresis (LA). Different intravenous (iv) formulations are used to treat ID in LA patients, however guidelines and data on ID/IDA management
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c6f63536d7db44bf1e5d8ae1f6ae82e1
https://doi.org/10.1016/j.atherosclerosissup.2015.02.030
https://doi.org/10.1016/j.atherosclerosissup.2015.02.030
Autor:
Volker J J, Schettler, Class L, Neumann, Christian, Peter, Thomas, Zimmermann, Ulrich, Julius, Eberhard, Roeseler, Franz, Heigl, Wolfgang, Ramlow, Helmut, Blume, E, Wieland
Publikováno v:
Atherosclerosis Supplements. 18:41-44
Objective In recent years the Federal Joint Committee (G-BA), a paramount decision-making body of the German health care system challenged the approval of diagnostic and therapeutic procedures for regular reimbursement, including lipoprotein apheresi
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ea5b9688360d7db3b24d1e81c32fa6fa
https://doi.org/10.1016/j.atherosclerosissup.2015.02.006
https://doi.org/10.1016/j.atherosclerosissup.2015.02.006